Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 13, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

March 1, 2026

Conditions
Transversalis Fascia Plane BlockIntrathecal DexmedetomidineCesarean Section
Interventions
OTHER

Transversalis fascia plane block

Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) with bilateral transversalis fascia plane (TFP) block (using 20 mL of bupivacaine 0.25%) at the end of surgery.

DRUG

Intrathecal dexmedetomidine

Patients will receive spinal anesthesia (using 2.5 mL of hyperbaric bupivacaine 0.5%) + (5 µg intrathecal dexmedetomidine diluted in 0.5ml saline) with a sham block at the end of surgery.

Trial Locations (1)

31527

RECRUITING

Tanta University, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT07170267 - Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section | Biotech Hunter | Biotech Hunter